Turns out nobody ever really wanted Bill Ackman at Valeant

Things could have been much different for Valeant Pharmaceuticals if former CEO Michael Pearson had stuck to his original guns about hedge fund billionaire Bill Ackman.
Apparently, Pearson didn't want Ackman anywhere near Valeant when the two first started talking. Neither did Valeant's board.
This weird tension is recounted in an amended complaint to the ongoing lawsuit between Ackman's Pershing Square hedge fund, Valeant, and investors in Allergan Pharmaceuticals.
It must've been love
Valeant